Journal
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY
Volume 9, Issue 6, Pages -Publisher
COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a022236
Keywords
-
Categories
Funding
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [RO1 AR060723]
- National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI122264, R21 AI108953]
- Rita Allen Foundation
- Office of the Director [DP2 AI112244]
- UC Hellman Award
- National Institutes of Health (NIH) [T32-CA9149-35]
- Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]
- National Center for Research Resources Grant [RR18928]
Ask authors/readers for more resources
Transforming growth factor beta (TGF-beta) is a pleiotropic cytokine involved in both suppressive and inflammatory immune responses. After 30 years of intense study, we have only begun to elucidate how TGF-beta alters immunity under various conditions. Under steady-state conditions, TGF-beta regulates thymic T-cell selection and maintains homeostasis of the naive T-cell pool. TGF-beta inhibits cytotoxic T lymphocyte (CTL), Th1-, and Th2-cell differentiation while promoting peripheral (p)Treg-, Th17-, Th9-, and Tfh-cell generation, and T-cell tissue residence in response to immune challenges. Similarly, TGF-beta controls the proliferation, survival, activation, and differentiation of B cells, as well as the development and functions of innate cells, including natural killer (NK) cells, macrophages, dendritic cells, and granulocytes. Collectively, TGF-beta plays a pivotal role in maintaining peripheral tolerance against self-and innocuous antigens, such as food, commensal bacteria, and fetal alloantigens, and in controlling immune responses to pathogens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available